001367.SZ
海森药业
SZSE · C 制造业 · CN
CNY 20.44
−6.24%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
12.9x
Market Cap
CNY 3.11B
MomentumView details →
1D Return
−6.24%
YTD Return
−7.11%
RSI (14)
55.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
12.9x
Market Cap
CNY 3.11B
RSI (14)
55.1
MomentumView details →
1D Return
−6.24%
YTD Return
−7.11%
Similar companies
Latest newsMore news →
Hysen Pharmaceutical announced its 2026 first-half results with revenue of 251 million yuan, up 3.64% year-on-year, and net profit attributable to shareholders of 65.7354 million yuan, up 8.13%.16d agoHysen Pharmaceutical announced that former chairman Wang Shiyue resigned and Wang Yuxiao was elected as the new chairman; former CFO Pan Aijuan resigned and Wu Suzhen was appointed as the new CFO.16d ago